PTC Therapeutics on Tuesday said the Food and Drug Administration has accepted its application seeking approval of its proposed sepiapterin treatment for phenylketonuria, a rare, inherited metabolic ...
The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease.
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...
Regeneron (REGN) and Sanofi's (SNY) asthma therapy Dupixent receives FDA approval for label expansion in treating certain ...
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY), Friday announced that the U.S. Food and Drug Administration has approved ...
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...
Regeneron REGN0.26%increase; green up pointing triangle Pharmaceuticals and Sanofi SAN 0.65%increase; green up pointing triangle have won U.S. Food and Drug Administration expanded approval of their ...
Women with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...
EAST HANOVER, NJ, USA I September 17, 2024 I Novartis today announced that the US Food and Drug Administration (FDA ... including those with node-negative (N0) disease 1. “The FDA approval of Kisqali ...
Novartis NVS announced that the FDA has approved breast ... with node-negative (N0) disease. Kisqali is a selective cyclin-dependent kinase inhibitor, a class of drugs that helps slow the ...
Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The regulatory body approved Kisqali in combination with an aromatase inhibitor (AI) ...
